JP2011518858A5 - - Google Patents

Download PDF

Info

Publication number
JP2011518858A5
JP2011518858A5 JP2011506689A JP2011506689A JP2011518858A5 JP 2011518858 A5 JP2011518858 A5 JP 2011518858A5 JP 2011506689 A JP2011506689 A JP 2011506689A JP 2011506689 A JP2011506689 A JP 2011506689A JP 2011518858 A5 JP2011518858 A5 JP 2011518858A5
Authority
JP
Japan
Prior art keywords
methyl
dihydro
methylsulfonyl
benzodioxin
amine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2011506689A
Other languages
English (en)
Japanese (ja)
Other versions
JP2011518858A (ja
JP5514804B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2009/055137 external-priority patent/WO2009133107A1/en
Publication of JP2011518858A publication Critical patent/JP2011518858A/ja
Publication of JP2011518858A5 publication Critical patent/JP2011518858A5/ja
Application granted granted Critical
Publication of JP5514804B2 publication Critical patent/JP5514804B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2011506689A 2008-04-29 2009-04-28 ドーパミン神経伝達のモジュレーター Expired - Fee Related JP5514804B2 (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
DKPA200800598 2008-04-29
DKPA200800598 2008-04-29
US4905908P 2008-04-30 2008-04-30
US61/049,059 2008-04-30
PCT/EP2009/055137 WO2009133107A1 (en) 2008-04-29 2009-04-28 Modulators of dopamine neurotransmission

Publications (3)

Publication Number Publication Date
JP2011518858A JP2011518858A (ja) 2011-06-30
JP2011518858A5 true JP2011518858A5 (enExample) 2012-06-14
JP5514804B2 JP5514804B2 (ja) 2014-06-04

Family

ID=40940061

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2011506689A Expired - Fee Related JP5514804B2 (ja) 2008-04-29 2009-04-28 ドーパミン神経伝達のモジュレーター

Country Status (15)

Country Link
US (1) US8524766B2 (enExample)
EP (1) EP2271634B1 (enExample)
JP (1) JP5514804B2 (enExample)
KR (1) KR20100135325A (enExample)
CN (1) CN102036976B (enExample)
AU (1) AU2009242092A1 (enExample)
BR (1) BRPI0911772A2 (enExample)
CA (1) CA2722978A1 (enExample)
DK (1) DK2271634T3 (enExample)
IL (1) IL208289A0 (enExample)
MX (1) MX2010011724A (enExample)
NZ (1) NZ588209A (enExample)
RU (1) RU2010141964A (enExample)
WO (1) WO2009133107A1 (enExample)
ZA (1) ZA201006932B (enExample)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2271635A1 (en) * 2008-04-29 2011-01-12 NSAB, Filial af NeuroSearch Sweden AB, Sverige Modulators of dopamine neurotransmission
MX2010011498A (es) 2008-04-29 2010-11-12 Nsab Af Neurosearch Sweden Ab Moduladores de neurotransmision de dopamina.
CN102180856B (zh) * 2011-03-01 2016-01-20 浙江华海药业股份有限公司 一种制备6-氟-3,4-二氢-2h-1-苯并吡喃-2-甲酸乙酯的方法
JP5876140B2 (ja) 2011-04-19 2016-03-02 インテグレイティブ・リサーチ・ラボラトリーズ・スウェーデン・アーベー 皮質のドーパミン作動性及びｎｍｄａ受容体介在のグルタミン酸作動性神経伝達の新規なモジュレータ
KR20160027218A (ko) 2012-05-23 2016-03-09 에프. 호프만-라 로슈 아게 내배엽 및 간세포를 수득하고 사용하는 조성물 및 방법
JP6481689B2 (ja) 2014-06-26 2019-03-13 住友化学株式会社 フェノール化合物の製造方法
US9125866B1 (en) 2015-01-28 2015-09-08 King Saud University Antidepressant compounds
CH712810B1 (de) * 2015-07-21 2020-07-15 Sumitomo Chemical Co Verfahren zur Herstellung einer 4-(Trifluormethylsulfonyl)phenol-Verbindung.
WO2020239568A1 (en) 2019-05-24 2020-12-03 Integrative Research Laboratories Sweden Ab Pharmaceutically acceptable salts of [2-(3-fluoro-5-methane-sulfonylphenoxy)ethyl](propyl)amine and uses thereof
WO2024182774A1 (en) * 2023-03-01 2024-09-06 Alexander Shulgin Research Institute, Inc. Deuterated and fluorinated empathogens

Family Cites Families (42)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3058980A (en) * 1962-10-16 Substitution products of benzo-
US2906757A (en) * 1959-09-29 Their preparation
DE1110175B (de) * 1957-01-08 1961-07-06 Rhone Poulenc Sa Verfahren zur Herstellung von Benzodioxanderivaten
JPS55124781A (en) * 1979-03-20 1980-09-26 Shionogi & Co Ltd 1,4-benzdioxanesulfonamide derivative
US5236055A (en) * 1991-03-13 1993-08-17 Canadian Aging & Rehabilitation Product Development Corporation Wheel with coaxial drive system mounted in the wheelhub field of the invention
US5189171A (en) * 1991-06-21 1993-02-23 American Home Products Corporation Antipsychotic benzodioxan derivatives
US5166367A (en) * 1991-06-21 1992-11-24 American Home Products Corporation Antipsychotic benzodioxan derivatives
US5126366A (en) * 1991-06-21 1992-06-30 American Home Products Corporation Aminophenoxyalkyl derivatives of benzodioxan
DE4135474A1 (de) * 1991-10-28 1993-04-29 Bayer Ag 2-aminomethyl-chromane
US5235055A (en) 1992-09-02 1993-08-10 American Home Products Corporation Antipsychotic quinoline derivatives of benzodioxanmethylamine
US5245051A (en) * 1992-09-03 1993-09-14 American Home Products Corporation Antipsychotic chroman derivatives of benzodioxanmethylamine
GB9514380D0 (en) * 1995-07-13 1995-09-13 Knoll Ag Therapeutic agents
US5663194A (en) * 1995-07-25 1997-09-02 Mewshaw; Richard E. Chroman-2-ylmethylamino derivatives
US5684039A (en) * 1995-07-25 1997-11-04 American Home Products Corporation Chroman-2-ylmethylamino derivatives
AR004229A1 (es) * 1995-11-06 1998-11-04 Wyeth Corp Derivados indolalquilo de benzodioxanmetilamina y su uso para preparar medicamentos
FR2791675B1 (fr) 1999-03-30 2001-05-04 Synthelabo Derives de n-[2-(4-aminophenyl) ethyl] -2,3-dihydro-1,4- benzodioxinne-2-methanamine, leur preparation et leur application en therapeutique
SE9904724D0 (sv) * 1999-12-22 1999-12-22 Carlsson A Research Ab New modulators of dopamine neurotransmission I
SE9904723D0 (sv) * 1999-12-22 1999-12-22 Carlsson A Research Ab New modulators of dopamine neurotransmission II
GB0007376D0 (en) 2000-03-28 2000-05-17 Knoll Ag Therapeutic agents
JP2005505586A (ja) * 2001-10-04 2005-02-24 ワイス ５−ヒドロキシトリプタミン−６リガンドとしてのクロマン誘導体
TWI281470B (en) * 2002-05-24 2007-05-21 Elan Pharm Inc Heterocyclic compounds which inhibit leukocyte adhesion mediated by alpha4 integrins
US20070208166A1 (en) * 2003-10-24 2007-09-06 Exelixis, Inc. Tao Kinase Modulators And Method Of Use
NZ550441A (en) * 2004-05-05 2009-07-31 Hoffmann La Roche Arylsulfonyl benzodioxanes useful for modulating the 5-HT6 receptor, the 5-HT2A receptor or both
KR101245075B1 (ko) * 2004-06-08 2013-03-18 엔에스아베 필리알 아프 뉴로서치 스웨덴 아베 스베리게 도파민 신경전달의 모듈레이터로서 신 2기치환된페닐피페리딘/피페라진
MY147767A (en) * 2004-06-16 2013-01-31 Janssen Pharmaceutica Nv Novel sulfamate and sulfamide derivatives useful for the treatment of epilepsy and related disorders
TW200612905A (en) * 2004-06-16 2006-05-01 Janssen Pharmaceutica Nv Novel sulfamate and sulfamide derivatives useful for the treatment of epilepsy and related disorders
US7713954B2 (en) * 2004-09-30 2010-05-11 Roche Palo Alto Llc Compositions and methods for treating cognitive disorders
BRPI0610046A2 (pt) * 2005-04-22 2010-05-25 Wyeth Corp derivados de benzodioxano e benzodioxolano e usos destes
SE529246C2 (sv) * 2005-10-13 2007-06-12 Neurosearch Sweden Ab Nya disubstituerade fenyl-piperidiner som modulatorer för dopaminneurotransmission
US20070155827A1 (en) * 2005-12-19 2007-07-05 Smith-Swintosky Virginia L Use of benzo-fused heterocycle sulfamide derivatives for the treatment of depression
US8716231B2 (en) * 2005-12-19 2014-05-06 Janssen Pharmaceutica Nv Use of benzo-fused heterocycle sulfamide derivatives for the treatment of pain
US8937096B2 (en) * 2005-12-19 2015-01-20 Janssen Pharmaceutica Nv Use of benzo-fused heterocyle sulfamide derivatives for the treatment of mania and bipolar disorder
US20070155824A1 (en) * 2005-12-19 2007-07-05 Smith-Swintosky Virginia L Use of benzo-fused heterocycle sulfamide derivatives for disease modification / epileptogenesis
US20070155823A1 (en) * 2005-12-19 2007-07-05 Smith-Swintosky Virginia L Use of benzo-fused heterocycle sulfamide derivatives as neuroprotective agents
US8691867B2 (en) * 2005-12-19 2014-04-08 Janssen Pharmaceutica Nv Use of benzo-fused heterocycle sulfamide derivatives for the treatment of substance abuse and addiction
AR058389A1 (es) 2005-12-19 2008-01-30 Janssen Pharmaceutica Nv Uso de derivados heterociclicos benzo-fusionados de sulfamida para el tratamiento de la obesidad
WO2007120596A1 (en) * 2006-04-12 2007-10-25 Wyeth DIHYDRO[1,4]DIOXINO[2,3-e]INDAZOLE DERIVATIVES AS 5-HYDROXYTRYPTAMINE-6 LIGANDS
AR060493A1 (es) * 2006-04-18 2008-06-18 Wyeth Corp Derivados de benzodioxano y benzodioxolano. procesos de obtencion.
EP2026790A2 (en) * 2006-05-19 2009-02-25 Janssen Pharmaceutica, N.V. Co-therapy for the treatment of epilepsy and related disorders
TWI457122B (zh) * 2007-07-20 2014-10-21 Orion Corp 作為用於治療周邊和中央神經系統疾病之alpha2C拮抗劑的2,3－二氫苯並[1,4]戴奧辛－2－基甲基衍生物
EP2271635A1 (en) 2008-04-29 2011-01-12 NSAB, Filial af NeuroSearch Sweden AB, Sverige Modulators of dopamine neurotransmission
MX2010011498A (es) 2008-04-29 2010-11-12 Nsab Af Neurosearch Sweden Ab Moduladores de neurotransmision de dopamina.

Similar Documents

Publication Publication Date Title
JP2011518858A5 (enExample)
RU2010141964A (ru) Модуляторы дофаминовой нейротрансмиссии
AU2002237654B2 (en) Piperazine derivatives, their preparation and their use for treating central nervous system (CNS) disorders
CN1060775C (zh) 用作神经递质重摄取抑制剂的稠合莨菪烷衍生物
RU2018130727A (ru) Органические соединения
JP2008538571A (ja) ジヒドロベンゾフラン誘導体およびその使用
RU2007139541A (ru) Производные хромана и хромена и их применение
CN1706813A (zh) 含长链脂肪酰基取代的文拉法辛前体药物及其制备方法和用途
WO2005079802A8 (en) Bipyridyl amides as modulators of metabotropic glutamate receptor-5
CN101203216A (zh) 二氢苯并呋喃衍生物及其用途
UA88719C2 (ru) Антагонисты рецепторов гистамина-3
WO2007088450A3 (en) Chromane antagonist of the h-3 receptor
JP2011518859A5 (enExample)
AU2002237654A1 (en) Piperazine derivatives, their preparation and their use for treating central nervous system (CNS) disorders
JP2005539068A5 (enExample)
JP2008538766A (ja) 薬物乱用の処置
JP2014518552A5 (enExample)
JP2011519839A5 (enExample)
RU2015148927A (ru) Производные изохинолина, стимулирующие нейрогенез
CN1154698A (zh) 苯并吡喃类化合物和它们作为治疗剂的用途
JP6173693B2 (ja) アリールピペラジンオピオイド受容体アンタゴニスト
JP2012509860A5 (enExample)
CA2672920A1 (en) Aryl piperazine derivatives useful for the treatment of neuropsychiatric disorders
RU2007142023A (ru) Пиперазин-замещенные бензотиофены для лечения психических расстройств
TW200534848A (en) 1-[2h-1-benzopyran-2-one-8-yl]-piperazine derivatives for the treatment of movement disorders